🇺🇸 Additional ocular hypotensive medication in United States

Additional ocular hypotensive medication (Additional ocular hypotensive medication) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Additional ocular hypotensive medication in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Additional ocular hypotensive medication approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Additional ocular hypotensive medication in United States?

Robin, Alan L., M.D. is the originator. The local marketing authorisation holder may differ — check the official source linked above.